Halka Arz Hisse Senedi LB Pharma, Bir Yılın Altında Üç Katına Çıktı. Devralma Hedefi mi?

Small biotech LB Pharmaceuticals (LBRX) is on a tear. The IPO stock has more than tripled in under a year as investors watch its efforts to take on Bristol Myers Squibb (BMY) and Johnson & Johnson (JNJ). The New York-based company has one drug: an oral formulation of the antipsychotic benzamide. It calls the drug LB-102. Benzamide is approved in…